Establishment of prognostic model for invasive ductal carcinoma with distant metastasis within the triple-negative breast cancer: a SEER population-based study
- PMID: 39724567
- DOI: 10.1097/CEJ.0000000000000925
Establishment of prognostic model for invasive ductal carcinoma with distant metastasis within the triple-negative breast cancer: a SEER population-based study
Abstract
Triple-negative breast cancer (TNBC) is a complex and diverse group of malignancies. Invasive ductal carcinoma (IDC) is the predominant pathological subtype and is closely linked to the ominous potential for distant metastasis, a pivotal factor that significantly influences patient outcomes. In light of these considerations, the present study was conceived with the objective of developing a nomogram model. This model was designed to predict the prognosis observed in IDC with distant metastasis in TNBC. This was a retrospective study based on the SEER database. Data of 9739 IDC-TNBC patients diagnosed from 2010 to 2020 were included in our study. Independent risk factors were screened by univariate and multivariate Cox regression analyses successively, which were used to develop a nomogram model predicting for prognosis. Cox multivariable analysis showed statistical significance in bone metastasis, liver metastasis, surgery, and chemotherapy. Incorporating statistically significant variables, as well as clinically significant age, lung metastasis, and brain metastasis into the construction of the prediction model, the C-indexes of the training group and validation group were 0.702 (0.663-0.741) and 0.667 (0.600-0.734), respectively, while the calibration curves were all close to the eideal 45° reference line, and decision curve analysis curves show excellent net benefit in the predictive model. The prognostic prediction model developed in this study demonstrated enhanced predictive accuracy, enabling a more precise evaluation of mortality risks associated with IDC with distant metastasis in TNBC.
Keywords: Surveillance, Epidemiology, and End Results database; invasive ductal carcinoma; nomogram; prognostic model; triple-negative breast cancer.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy.Sci Rep. 2025 Jul 1;15(1):21666. doi: 10.1038/s41598-025-05738-y. Sci Rep. 2025. PMID: 40596034 Free PMC article.
-
Natural history and prognostic nomogram of untreated triple negative breast cancer based on SEER database.Sci Rep. 2025 Jul 2;15(1):23347. doi: 10.1038/s41598-025-07114-2. Sci Rep. 2025. PMID: 40603958 Free PMC article.
-
Establishment of a prognostic nomogram and risk stratification system for patients with distant-metastatic hepatocellular carcinoma: A population-based study.Medicine (Baltimore). 2025 Jun 13;104(24):e42834. doi: 10.1097/MD.0000000000042834. Medicine (Baltimore). 2025. PMID: 40527819 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
References
-
- Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T (2018). Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res. 8:1483–1507.
-
- Batra H, Mouabbi JA, Ding Q, Sahin AA, Raso MG (2023). Lobular carcinoma of the breast: a comprehensive review with translational insights. Cancers (Basel). 15:5491.
-
- Bonotto M, Gerratana L, Poletto E, Driol P, Giangreco M, Russo S, et al. (2014). Measures of outcome in metastatic breast cancer: insights from a real-world scenario. Oncologist. 19:608–615.
-
- Borri F, Granaglia A (2021). Pathology of triple negative breast cancer. Semin Cancer Biol. 72:136–145.
-
- Dai D, Jin H, Wang X (2018). Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study. Am J Cancer Res. 8:1576–1585.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical